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Abstract
Background: Angiotensin II (Ang II) signaling, including matrix metalloproteinase type II (MMP2) activation, has been linked
to an age-associated increase in migration capacity of vascular smooth muscle cells (VSMC), and to other proinflammatory
features of arterial aging. Calpain-1 activation is required for MMP2 expression in fibroblasts and is induced in
cardiomyocytes by Ang II. The consequences of engagement of calpain-1 with its substrates, however, in governing the
age-associated proinflammatory status within the arterial wall, remains unknown.
Methodology/Principal Findings: The present findings demonstrate that transcription, translation, and activity of calpain-1
are significantly up-regulated in rat aortae or early-passage aortic VSMC from old (30-mo) rats compared to young (8-mo).
Dual immunolabeling of the arterial wall indicates that colocalization of calpain-1 and Ang II increases within the aged
arterial wall. To further explore the relationship of calpain-1 to Ang II, we chronically infused Ang II into young rats, and
treated cultured aortic rings or VSMC with Ang II. We also constructed adenoviruses harboring calpain-1 (CANP1) or its
endogenous inhibitor calpastatin (CAST) and infected these into VSMC. Ang II induces calpain-1 expression in the aortic
walls in vivo and ex vivo and VSMC in vitro. The Ang II mediated, age-associated increased MMP2 activity and migration in
VSMC are both blocked by calpain inhibitor 1 or CAST. Over-expression of calpain-1 in young VSMC results in cleavage of
intact vimentin, and an increased migratory capacity mimicking that of old VSMC, which is blocked by the MMP inhibitor,
GM6001.
Conclusions/Significance: Calpain-1 activation is a pivotal molecular event in the age-associated arterial Ang II/MMP2
signaling cascade that is linked to cytoskeleton protein restructuring, and VSMC migration. Therefore, targeting calpain-1
has the potential to delay or reverse the arterial remodeling that underlies age-associated diseases i.e. atherosclerosis.
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Introduction
A growing body of evidence indicates that aging is the major
risk factor for the development of the quintessential cardiovascular
diseases i.e. atherosclerosis, hypertension, and stroke [1–8]. It is
well-known that aging induces several changes in vascular
structure and function, i.e., increases in arterial intimal-medial
thickness, arterial stiffness, and a proinflammatory state [1–8].
These alterations appear to be closely linked to enhanced arterial
wall angiotensin II (Ang II) signaling [9–12]. Prior studies have
demonstrated that the arterial wall or vascular smooth muscle cells
(VSMC) of old rats have an over-abundance of the renin
angiotensin system (RAS) components, including Ang II and its
downstream molecular cascade, e.g. transforming growth factor-
beta1 (TGF- b 1), extracellular matrix metalloproteinase type II
(MMP2), endothelin-1 (ET-1), monocyte chemoattractant protein
-1 (MCP-1), and reactive oxygen species (ROS) [8–17].
Calpain-1, a ubiquitous, cytosolic Ca
2+ activated neutral
protease, is a heterodimeric molecule which consists of a large
80 kDa catalytic and a small 30 kDa regulatory subunit [18,19].
Calpain-1 activation is linked to the cellular Ca
2+ loading status in
a dose–dependent manner within living cells [20]. Prior studies
indicate that calpain is of potential importance in the regulation of
the proteolysis of key enzymes and structural proteins as well as
proinflammatory responses [21–28]. Calpain-1 mediates MMP2
expression, and consequently affects the invasion of fibroblasts and
leukemic cells [23,24]. Increased MMP2/9 is a characteristic
feature of central arterial aging in rats, nonhuman primates, and
humans [8,11,12,29], and MMP2/9 activation plays a crucial role
in age-associated VSMC migration, elastin degradation, and
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vimentin and spectrin by calpain-1 is required for the attachment
and spreading of fibroblasts [18–22]; Further, calpain-1 activation
is necessary for the cardiomyocyte hypertrophy induced by Ang II
[32] and for the MCP-1 secretion from VSMC stimulated by IL-
1a [25]. In fibroblasts calpain-1 is also an effective activator of the
profibrogen TGF-b1, which results in the production of
extracellular matrices [31,33].
The consequences of the physiological engagement of calpain-1
with its substrates are important because the spectrum of calpain
actions strikingly resemble those that accompany aging of the
arterial wall. We hypothesized that calpain-1 activity increases
with aging and mediates some of the aforementioned aspects of the
age-associated arterial wall proinflammatory state. In the present
study, we demonstrate that the levels of transcription, translation,
and activation of calpain-1 are significantly up-regulated in rat
aorta or early-passage aortic VSMC from old rats compared to
their young counterparts. In an attempt to define a specific role for
calpain-1 in the arterial aging process, we constructed recombi-
nant adenoviruses harboring cDNA of calpain-1 or its endogenous
inhibitor calpastatin, and infected VSMC. We also infused Ang II
into rats to determine its effect on calpain-1 levels and activity.
The results show that calpain-1 activation appears to be a pivotal
event in the age-associated arterial Ang II/MMP2 signaling
cascade, including MMP2 activation, cytoskeleton protein restruc-
turing, and VSMC migration. Thus, calpain-1 activation is central
to the initiation and progression of proinflammation in the arterial
wall with advancing aging.
Results
The levels of calpain-1 transcript, protein abundance and
activity increase within the aged aorta
The quantitative reverse transcription polymerase chain
reaction (qRT-PCR) showed that the transcript level of calpain-
1 increased 1.8 fold within the aortic wall in old (30 mo) compared
to young (8 mo) rats (Fig. 1A); Western blot analysis indicated that
calpain-1 protein abundance increased 1.3-fold (p,0.05) with age
(Fig. 1B). In addition, dual immunolabeling of en face medial
aortic sections demonstrated that increased calpain-1 protein
within old rats was co-localized with a-smooth muscle actin (a-
SMA), a marker of VSMC, stained cells (Fig. 1C, lower right-
most panel). The levels of cleaved spectrin fragments predict
calpain activity. In aortic lysates of old rats Fig. 1D (left panel)
three conspicuous spectrin bands, designated as intact (250 kDa)
and cleaved spectrin fragments (145, and 150 kDa) respectively,
are observed. In contrast, only intact spectrin was detected in
young rat aortic lysates. Thus, on the basis of cleaved spectrin
fragments old rats have a 3.3 fold increase in aortic calpain activity
compared to their young counterparts (Fig. 1D, right panel).
Ang II enhances calpain-1 transcription, translation, and
activity
Ang II is a known stimulator of calpain-1 expression in
cardiomyocytes [32]. Prior studies have shown that Ang II protein
abundance increases in the aged aortic wall in vivo and in VSMC
in vitro [8,11,12]. To determine if Ang II induces calpain
activation in the arterial wall with advancing age, we have
performed in vivo, ex vivo and in vitro experiments. Double
immunolabeling of VSMC showed that increased Ang II is co-
localized with increased calpain-1 in VSMC from old aortae
(Fig. 2A, yellow color, right lower panel). We attempted to
reproduce features of arterial aging in specimens from young
animals. A 28 day infusion of Ang II into young rats (8mo)
increases aortic calpain-1 protein staining (Fig. 2B), protein
abundance by 1.5 fold (Fig. 2C), and activity by 1.2 fold
(Fig. 2D) compared to the saline infused (control). Thus calpain-1
activation follows Ang II exposure in young aortae, resembling
that of untreated old animals in Fig. 1.
Ang II infusion in vivo alters both circulating cells and
hemodynamic factors [11,34], both of which may affect the
expression and activity of arterial calpain-1. To avoid these issues
we utilized exposed organoid cultures of aortic rings from young
rats, which retain the anatomic relationship among the cells of the
vessel, to Ang II (10
27 mol/L) for 48 hrs. Calpain-1 protein
abundance was increased by 1.7 fold (Fig. 3A) and activity by 1.2
fold (Fig. 3B), up to the levels of untreated arterial rings from old
rats.
To determine whether VSMC in vitro (p3-p5), in fact, retain
their properties in vivo, aortic VSMC were isolated from young
and old animals. Indeed, calpain-1 transcriptome (Fig. 4A),
protein expression abundance (Fig. 4B & 4C), as well as activity
(Fig. 4D) were up-regulated within old VSMC compared to
young cells. Further, qRT-PCR analysis indicated that Ang II
induces young VSMC to increase calpain-1 transcription in a
dose-dependent manner, achieving the level of untreated old cells
(Fig. 4A). Likewise, treatment of young cells with Ang II increases
calpain-1 protein abundance in a dose-dependent fashion, to the
level of untreated old cells (Fig. 4B). Interestingly, the age- and
Ang II-associated increases in calpain-1 protein and activity are
substantially reduced by [Sar
1, Gly
8]-Angiotensin II acetate
hydrate (SG), an AT1 receptor antagonist (Fig. 4C & D).
Calpain-1 mediates Ang II associated activation of MMP2
We have previously shown that Ang II increases MMP2
activation in the arterial wall in vivo and ex vivo and in isolated
VSMC in vitro [11]. Since both calpain-1 and MMP2 are
involved in the attachment, spreading, and migration of both
fibroblasts and VSMC [8,11,23,24], we sought to demonstrate a
link between calpain-1 and MMP2 activation. Fig. 5A shows that
Ang II increased MMP2 activity in a dose-dependent manner in
young VSMC, up to the level of untreated old cells. The increased
MMP activity induced by Ang II was abolished by Ci 1, a non-
specific calpain inhibitor (Fig. 5B). Additionally MMP2 activity
within untreated young and old VSMC was substantially inhibited
by Ci 1 (Fig. 5B). To confirm a specific role of calpain-1 in Ang
II induced MMP2 activation, young VSMC infected with a virus
harboring calpastatin (CAST), an ectopic expression of the
endogenous calpain inhibitor, were exposed to Ang II. Figure
S1A (Fig S1 A) demonstrates that CAST over-expresses
calpastatin in cultured VSMC. The infection with CAST virus
substantially reduced MMP2 activity both in Ang II treated young
cells and in old untreated cells (Fig. 5C).
Calpain-1 remodels the cytoskeleton within VSMC
With aging, alterations of VSMC cytoskeletal proteins such as
a-SMA and vimentin occur concomitantly with changes in VSMC
migration rates [35]. Fig. 6A demonstrates that within the old
VSMC increased calpain-1 colocalizes with vimentin (Fig. 6A,
lower right panel, yellow color) and a-SMA (data not shown).
Casein zymography (Fig. 6B, upper panel) confirms that calpain-
1 but not calpain-2 activity in VSMC increase with age. Over-
expression of calpastatin did not affect calpain-1 activity in young
VSMC, although it decreased calpain-1 activity in old cells.
Moreover, calpain-2 activity was not affected by over-expression of
calpastatin in either young or old VSMC. These inconsistent
effects may be due to different calcium requirements for
calpastatin binding to calpain-1 or calpain-2 [36]. Cytosolic
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2+]) are known to increase with aging
[37]. A single vimentin cDNA encodes a 57-kDa intact protein
[27]. In addition, we observed intact vimentin protein only in early
passage young VSMC, but not in old cells, which showed only
small vimentin fragments (Fig. 6B). Further, several small
fragments are disproportionately distributed in young and old
cells: while both young and old cells share fragments II and III,
fragment I is more abundant in young cells (Fig. 6B,8 m o
control), while fragment IV is unique to old cells (Fig. 6B,3 0m o
controls).
This characteristic age-associated shift of vimentin fragments
suggests that arterial wall calpain-1 may cleave the intact vimentin,
generating multiple proteolytic fragments. To test this hypothesis,
we also constructed and amplified adenoviruses harboring calpain-
1 and over-expressed calpain-1 in VSMC in Figure S1 B. Indeed,
infection of adenoviruses harboring calpain-1 (CANP1) into young
VSMC dramatically increases calpain-1 activity (Fig. 6B, upper
panel) and generates a multiple proteolytic fragment pattern
(Fig. 6B, lower panel, 8 mo), similar to old uninfected or
CANP-1 infected cells (Fig. 6B, lower panel, 30 mo).
Remarkably, infection of old VSMC with an adenovirus harboring
CAST indeed inhibits calpain-1 activity (Fig. 6B, upper panel)
and generates a pattern of proteolytic products of vimentin
resembling that from the untreated young cells (Fig. 6B, lower
panel, 30 mo).
The interactions of calpain-1, a-SMA, spectrin, and vimentin
that occur concomitantly with changes in SMC migration with
advancing age suggest that the dynamic changes in distribution of
calpain associated cytoskeletal proteins may play a role in VSMC
attachment and spreading, crucial processes of cell migration. We
next determined the spatial and temporal location of endogenous
calpain-1 in the attachment processes of VSMC by using time-
lapse photomicrography. Fig. 6C demonstrates that at the
initiation of attachment, calpain-1(red) is abundantly aggregated
in the perinuclear region (0 hr), and then begins to protrude
outwardly as the cell becomes attached to the substratum (3 hrs).
At 5 hrs, the cell has become attached, as shown by a completed
circular border with calpain-1 preferentially localized at the
Figure 1. Calpain-1 transcriptome, protein abundance, and activity increase in the aged aortic wall. A. Average data of calpain-1
transcriptome. B. Western blots for calpain-1 protein of rat intact aortae (upper panel); average data (lower panel). C. Dual en face fluorescence
staining for a-SMA (green), calpain-1 (red) in the medial aortic sections from young (upper panels) and old rats (lower panels). Nuclei were
counterstained with DAPI (blue). Merged image is depicted in right panel (yellow-blue). Magnification:6400. D. Western blots for calpain substrate a-
II spectrin from aortic lysates (left panels). Average cleaved spectrin fraction (right panel). *p,0.05, old vs. young.
doi:10.1371/journal.pone.0002231.g001
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have taken place and calpain-1 has continuously expanded
peripherally, accompanied by the formation of lammellipodia.
Finally, calpain-1 is uniformly distributed once the cell has
achieved a fully spread state (24 hrs).
Catalytic activation of calpain-1 is required for age-
associated enhancement of VSMC migration
Data presented thus far show calpain-1 within VSMC co-
localizes with vimentin (Fig. 6A), is capable of cleaving spectrin
[18], vimentin (Fig. 6B), and a-smooth muscle actin (data not
shown), and is also linked to Ang II induced activation of MMP2.
We addressed the idea that calpain-1 plays a role in MMP2
activation and cytoskeleton restructuring, crucial events relevant to
age-associated increased VSMC migration. Fig. 7A shows that the
random migration capability of early passage VSMC from old rats
is increased 1.9 fold compared to that of young VSMC (p,0.05).
Interestingly, Ci 1, the exogenous cell–permeable calpain
inhibitor, dramatically reduces the random migratory capability
of both young and old cells (Fig. 7A).
The increased Ang II protein expression within older VSMC is
accompanied by an increased gradient of intimal-medial PDGF-
BB in the old aorta [11,38]. PDGF-BB, a potent chemoattractant,
enhanced VSMC chemotaxis by 9.1–fold for young (85.462.4 vs.
9.160.6 cells/field, p,0.05) and by 6.1-fold for old cells
(103.665.2 vs. 17.261.0 cells/field, p,0.05). Fig. 7B (upper
panel) shows that Ang II treatment increases the migration
capacity of young VSMC to the level of untreated old cells.
Strikingly, Ci 1 completely abolished the Ang II-/PDGF-BB-
induced chemotaxis of both young and old cells. Infection of the
adenovirus harboring CAST completely abolished the Ang II-
induced VSMC migration increase (Fig. 7B, lower panel).
To bypass both Ang II and PDGF-BB signaling, we infected
young VSMC with an adenovirus harboring calpain-1 (CANP1) or
calpastatin (CAST) cDNA. Over-expression of CANP1 enhanced
the migratory ability of young VSMC by 1.5-fold (p,0.05), up to
Figure 2. Calpain-1 induction in vivo by Ang II. A. Dual fluorescence labeled calpain-1 (green) and Ang II (red) in the en face medial aortic
sections from young (upper panels) and old rats (lower panels). Merged image (right panels, yellow). Nuclei were counterstained with DAPI (blue).
Magnification:6400. B. Photomicrographs (X400) of carotid sections stained for calpain-1 protein (brown color) from young rats infused chronically
with Ang II 200 ng/kg/min for 28 days. L=lumen; and M=media. C. Western blots of calpain-1 and b-actin of carotid lysates from young rats infused
with saline solution (control) and Ang II (left panel); right panel shows average data. D. Western blots of the calpain substrate, a-II spectrin, of carotid
arteries (left panels). Average cleaved spectrin fraction (right panel). *p,0.05, Ang II vs. saline infusion.
doi:10.1371/journal.pone.0002231.g002
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sion of calpastatin reduced the migratory capability of old cells, to
the level of young cells infected with GFP alone (Fig. 7C).
Further, the increased chemotaxis induced by CANP1 infection in
both young and old cells was substantially reduced by GM6001,
an MMP inhibitor (Fig. 7D). In addition, GM6001 substantially
inhibited the migration of old cells (Fig. 7D).
Discussion
Our study documents multiple novel roles of calpain-1 in age-
associated vascular restructuring in rats. First, we show that the
levels of transcript, protein and activity of calpain-1 within the
aged aortic wall and isolated VSMC increase with advancing age.
Second, increased Ang II within the aged aortic wall or VSMC
[11], per se, mediates the expression and activation of calpain-1.
Third, activated calpain-1 is necessary for activation of MMP2
within VSMC, a characteristic feature of the aged aorta. Fourth,
increased calpain-1 activity is involved in the exaggerated cleavage
of cytoskeletal proteins, including spectrin and vimentin, in old
VSMC. Finally, the catalytic activity of calpain is required for the
efficient chemotaxis of VSMC induced by Ang II or PDGF-BB.
Our results show that increased Ang II within the aged aortic
wall or VSMC stimulates the expression and activation of calpain-
1 in vivo, ex vivo and in vitro. Chronic infusion of Ang II into young
rats for 28 days enhances calpain-1 protein abundance and
activation in the arterial wall, similar to that of the old animal.
Ang II infusion, in vivo, effects changes in multiple factors, i.e.
circulating cells and hemodynamics [11,34], each of which
impacts on the expression and activation of calpain-1 [39–41].
We employed an organoid culture of arterial rings to show that as
anticipated, Ang II treatment, per se, in young VSMC promotes
calpain-1 expression and activation, reaching the levels of rings
from old untreated rats. Further, exposure of isolated VSMC from
young rats to Ang II increases the activity of calpain-1 to the levels
of untreated cells. These effects are substantially inhibited by SG,
an AT1 receptor antagonist. The present results are consistent
with previous reports in other cells or organs that support the idea
that AT1 signaling exerts a causal role in calpain-1 activation.
[32,42,43]. Factors present in the aged arterial wall facilitate the
transcriptional and post-translational modification of calpain-1
that leads to its activation.
The transcriptional activation of calpain involves the promoter/
enhancer motif, 12-o-tetradecanoyl-phorbol-13-acetate response
element (TRE), which binds AP-1 [28,44], a dimer consisting of c-
fos and c-jun [45]. AP-1 activity in the nuclei of VSMC which is
directly or indirectly triggered by Ang II, and its associated
signaling molecules ET-1, epinephrine, and ROS [8–15,17,46,47],
likely switches on calpain-1 gene transcription [28,46,48,49].
Further, the age-associated increase of these vasoactive factors
within the arterial wall open L-and T-type calcium channels,
increasing Ca
2+ influx or redistributing intracellular stored Ca
2+,
contributing to a transient increase in cytosolic Ca
2+ [50,51],
which provides a niche for facilitating the activation of calpain-1
following its translation.
Increased MMP2 activity, due in part to age-associated
increases in aortic wall MT1MMP and reductions of TIMP2, is
a characteristic feature of the aged arterial wall [12]. The present
findings suggest that calpain-1 activation is a most likely event
within the Ang II/MMP2 signal axis during arterial aging because
calpain-1 activation is necessary for Ang II induced activation of
MMP2 within VSMC. When young VSMC are exposed to Ang
II, MMP2 activation increases in a dose-dependent manner, up to
the level of old untreated cells. Importantly, increased MMP2
activity is completely abolished by Ci 1, an inhibitor of calpain.
Further, Ci 1 treatment also substantially reduces MMP2
Figure 3. Calpain-1 induced ex vivo by Ang II. A. Western blots of calpain-1 and b-actin of arterial rings from young and old rats treated with
Ang II for 72 hrs (left panels); average data (right panel). B. Western blots of the calpain substrate, a-II spectrin, of arterial rings from young and old
rats treated with Ang II for 72 hrs (left panel); average data of cleaved a-II spectrin fraction (right panel). *p,0.05, vs. young untreated rings (control).
doi:10.1371/journal.pone.0002231.g003
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are endorsed by previous reports in fibroblasts and leukemic cells
[23,24]. Neither MMP2 mRNA, nor MMP2 activity can be
detected in a calpain-1 null mouse embryonic fibroblast
transformed by SV40 large T-antigen (TAg-capn 4 -/-mEF)
[23]. However, in TAg-capn4-/-mEF, a low level of secreted
MMP2 is restored by transfection with a vector expressing rat
calpain, which partially restores calpain activity [23]. Interestingly,
the calpastatin-derived calpain inhibitor, CP1B, reduces mRNA
expression and secretion of MMP2 in the leukemic cell line THP-
1[24]. In addition, we also demonstrate that an infection of VSMC
with CAPN1 increases the transcription and protein expression of
MT1-MMP, an activator of MMP2, and decreases protein levels
of TIMP2, an inhibitor of MMP2 (Jiang LQ, unpublished data).
Thus, calpain-1 activation has a role in creating an imbalance of
MMP2 activators and inhibitors that contribute to increased
MMP2 activity within VSMC.
VSMC exhibit a striking plasticity and are able to change from
a differentiated contractile phenotype to a more immature,
synthetic phenotype with aging [2,3]. This includes a prominent
cytoskeletal reorganization and construction of a large secretory
apparatus to produce Ang II, MMP2, MCP-1, and latent TGF-b1
[11,12,16,31]. As a result, the aged cells lose their contractility and
are able to migrate, proliferate, and secrete extracellular matrix
Figure 4. Calpain-1 induction in vitro by Ang II. A. Average calpain-1 transcript abundance from VSMC treated with Ang II for 48 hrs,
determined by real time RT-PCR. B. Western blots of calpain-1 of early passage VSMC treated with Ang II for 48 hrs (left panels); average data (right
panel). C. Western blots of calpain-1 of early passage VSMC treated with Ang II (10
27mol/L) and or SG (10
27mol/L), an AT1 antagonist, for 48 hrs (left
panels); average data (right panel). D. Western blots of a-II spectrin of early passage VSMC treated with Ang II (10
27mol/L) and or SG (10
27mol/L), an
AT1 antagonist, for 48 hrs (left panels); average data (right panel). *p,0.05, vs. young untreated VSMC (control). #p,0.05, vs. Ang II treated young
VSMC. $p,0.05, vs. old untreated VSMC.
doi:10.1371/journal.pone.0002231.g004
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in the remodeling of the arterial wall with aging. The increased
calpain-1 is involved in the restructuring of the cytoskeleton, which
includes actin, spectrin, and vimentin, within VSMC with aging
[35]. Our results support the idea that the catalytic activity of
calpain is an unequivocal critical regulator of efficient VSMC
chemotaxis. We show that cytoskeletal proteins are substrates of
natural or ectopically expressed endogenous calpain-1 within
VSMC, and that calcium-dependent vimentin cleavage was
substantially inhibited by the ectopic over-expression of a calpain
inhibitor, calpastatin. The strikingly different pattern of multiple
fragments of vimentin in young and old VSMC in this present
study reflect the importance of cytoskeleton remodeling with age.
Since the cytoskeleton plays a crucial role in the attachment,
spreading, and migration of cells [18,19,22,24,26,27,52], it is
reasonable that age-associated changes in calpain are involved in
age differences in the attachment and spreading of VSMC.
In the present study, we further confirm that VSMC migratory
capability increases with aging [8,9,11,16,35]. This age-associated
VSMC migration increase is exaggerated by Ang II treatment,
over-expression of calpain-1, and PDGF-BB chemoattractant. The
catalytic activity of calpain is required for efficient chemotaxis of
VSMC induced by Ang II or PDGF-BB. These effects are
abrogated by GM6001, an MMP2 inhibitor, or calpain-1
inhibitor, Ci 1, or over-expression of calpastatin. Notably, Ci l
unselectively reduces the migration capacity of VSMC from both
young and old animals. These results are consistent with reports
on fibroblast and THP-1 cells [23,24]: interruption of calpain
activation can impair cell movement, as shown in calpain-deficient
mouse fibroblasts and CHO cells, while over-expression of
calpastatin or exogenous calpain inhibitor impedes cell spreading
and migration.
In summary, our results demonstrate an age-associated increase
of calpain-1 gene transcripts, protein levels and activity in the old
aortic wall; increased Ang II induces calpain-1 expression in the
aortic walls in vivo and ex vivo and VSMC in vitro; the Ang II
mediated age-associated increased MMP2 activity, is blocked by
calpain inhibitor 1 or CAST, indicating that calpain activity is
required for MMP activation by Ang II treatment. An increase in
old VSMC migratory capacity is mimicked in young VSMC by
Figure 5. Ang II induces activity of MMP2 mediated by calpain-1 activation. A. A representative PAGE gelatin zymogram from young and
old VSMC treated with Ang II for 48 hrs. B. A representative PAGE gelatin zymogram of VSMC treated with Ang II, or Ci 1, a calpain inhibitor, for 48 hrs
(left panel); average data (right panel). C. A representative PAGE gelatin zymogram of VSMC infected adenovirus harboring GFP or CAST treated with
Ang II (left panels); average data (right panel). *p,0.05, vs. young untreated VSMC (control). #p,0.05, vs. Ang II treated young VSMC. $p,0.05, vs.
old untreated VSMC.
doi:10.1371/journal.pone.0002231.g005
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increased calpain-1 activity, as a central component of the
exaggerated Ang II signaling pathway, which is involved in age-
associated arterial remodeling. Thus, targeting calpain-1 is a
potential approach to delay or reverse the age-associated arterial
remodeling that is also associated with diseases such as
hypertension, atherosclerosis, and stroke.
Materials and Methods
Animals and Ang II infusion
8-month (young, n=40) and 30-month (old, n=20) Fisher 344
X Brown Norway (F344XBN) male rats were obtained from the
National Institute on Aging contract colonies (Harlan Sprague-
Dawley, Indianapolis). Twenty young rats were randomly
allocated into 2 groups, and implanted subcutaneously with
osmotic minipumps (Model 2004, Alzet Corp) in the midscapular
region, according to methods described previously [11]. Briefly,
rats were infused with Ang II at a rate of 200 ng/kg/min (Ang II
infusion, n=10) and rats infused with saline served as untreated
young controls (control, n=10). The animal protocol was
approved by the Institutional Animal Care and Use Committee
and complied with the guide for the care and use of laboratory
animals (National Institutes of Health publication No. 3040-2,
revised 1999).
All of the animals were sacrificed by an overdose of sodium
pentobarbital, and thoracic aortae were immediately removed,
isolated, and processed as described previously [11]. In addition, a
3–4 mm in length segment of thoracic aorta from young and old
rats (n=4 per group) was explanted. This segment was cut
longitudinally, flattened on a wooden board, and embedded in
paraffin for en face observation by immunofluorescence.
Organ Culture
Aortic rings were explanted and cultured as described
previously [11,31]. Briefly, after dissection of adventitial tissue,
aortic segments were placed in 6-well dishes containing
DMEM+F12 (1:1) (GIBCO BRL) and antibiotics (penicillin
Figure 6. Calpain-1 and vimentin interactions within VSMC. A. Photomicrographs of dual labeling for calpain-1 (green) and vimentin (red)
within VSMC from young (left panels) and old rats (right panels); merged image (yellow bottom panels). B. Casein zymogram of VSMC from young
and old VSMC infected with a CANP1 or CAST virus (upper panel). Western blots of vimentin from young and old VSMC infected with CANP1 or CAST
virus (lower panel). Proteolytic fragments are indicated by arrows and designated I-V. C. Fluorescence labeled calpain-1 protein of VSMC isolated
from young rat aortae. VSMC were isolated from the aorta of 8-month-old rat, allowed to adhere on a fibrogen matrix, fixed with methanol and
acetone, and stained with calpain-1 antibody (red). The nuclei were counterstained with DAPI (blue). Magnification 6400.
doi:10.1371/journal.pone.0002231.g006
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transferrin 5 mg/ml, and insulin 5 mg/mL. The vessel segments
were then maintained in a tissue culture incubator at 37uC and
exposed to various experimental conditions for the times indicated.
The vascular segments were frozen in liquid nitrogen and the
supernatants were stored at 280uC until use.
Generation of recombinant adenoviruses
The human calpain-1 full-length cDNA fragment was obtained
as described previously [39]. The calpain-1 cDNA (2210 bp) was
amplified by polymerase chain reaction (PCR) with primers
containing Xho I and Hind III restriction sites at the 59 and 39
ends, respectively. The upstream primer is 59-CTCGAGCAC-
CATGTCGGAGGAGATC-39 and the downstream primer is
59-AAGCTTGGCAGACGAGGAGGGAGG-39. The rat calpas-
tatin full-length cDNAs were amplified by reverse transcription-
PCR (RT-PCR) from 2 mg of total RNA extracted from rat aorta.
The primers for the calpastatin cDNA fragment (2003 bp) which
added Kpn I and Xba I restriction sites at the 59 and 39 ends
respectively were as follows: 59-GGTACCTCTCCCAGAAT-
GAG-39 59- TCTAGATACCAAAATGCATAAAC-39. The
PCR fragments were ligated to the pGEM-T vector and
sequenced. The calpain-1 and calpastatin were then cut by Xho
I and Hind III or Kpn I and Xba I, respectively and then ligated
to pAdTrack-CMV which has a reporter gene expressing green
fluorescent protein. The adenoviral backbone plasmid pAdEasy-1
and shuttle plasmid pAdTrack-CMV were a gift from Dr Bert
Vogelstein (John Hopkins Oncology Center Baltimore Maryland,
Figure 7. VSMC migration. A. The random migration of VSMC. *p,0.05, vs. young; and #p,0.05, vs. young or old untreated control cells B. The
migration of VSMC treated with Ang II or Ci1 (upper panel) or infected with or without a CAST virus (lower panel), in response to a PDGF-BB gradient
(10ng/ml) *p,0.05, vs. young untreated VSMC (control). #p,0.05, vs. Ang II treated young VSMC. $p,0.05, vs. old untreated VSMC. C. The random
migration of VSMC infected with a CANP1 or CAST virus. *p,0.05, vs. young; and #p,0.05, vs. young infected with CANP1 virus. $p,0.05 vs. old
infected with control (GFP) virus. D. The random migration of VSMC infected with CANP1 or GM6001. *p,0.05, vs. young; and #p,0.05, vs. young
infected with CANP1 virus. $p,0.05 vs. old infected with control (GFP) virus.
doi:10.1371/journal.pone.0002231.g007
Calpain-1 and Arterial Aging
PLoS ONE | www.plosone.org 9 May 2008 | Volume 3 | Issue 5 | e2231USA). The replication-defective recombinant adenovirus encoded
calpain-1 (CANP1) or calpastatin (CAST) together with green
fluorescent protein were constructed by homologous recombina-
tion, as described in a previous study [53]. An adenoviral vector
expressing green fluorescent protein (GFP) served as a control
virus. Standard viral amplification and cesium chloride purifica-
tion methods were used to amplify and purify these adenoviruses.
The titer for each adenovirus in HEK293A cells was determined
via a dilution assay.
VSMC Isolation, culture, and infection
Vascular smooth muscle cells were enzymatically isolated and
cultured as previously described [16]. Briefly, F344XBN rat
thoracic aortas were rinsed in Hanks balanced salt solution (HBSS)
containing 50 mg/mL penicillin, 50 mg/mL streptomycin and
0.25 mg/mL amphotericin B (Gibco). After digestion for 30 min in
2 mg/mL collagenase I solution (Worthington Biomedical,
Freehold, New Jersey) at 37uC, the adventitia and intima were
removed from the vessel media layer, which was placed overnight
in complete medium (DMEM plus 10% FCS). On day 2 the
vascular media was further digested with 2 mg/mL collagenase
II/0.5 mg/mL elastase (Sigma) for 1 hour at 37uC, and the
isolated cells were washed and plated in complete medium. In all
cases, .95% of cells stained positive for a-smooth muscle actin (a-
SMA).
Early passage (p3-p5) VSMC were untreated, or pre-treated
with Ang II (100 nmol/L) only or together with [Sar
1, Gly
8]-
Angiotensin II acetate hydrate (SG, Cat# A-7401, Sigma, St.
Louis, MO) (100 nmol/L), an AT1 blocker, or together with the
calpain inhibitor, Ci 1 (100 mmol/L, Cat# 208719, Calbiochem,
San Diego, CA) for 48 hours in 0.1% FBS for Western blot and
Polyacrylamide Gel Electrophoresis (PAGE) gelatin zymographic
analysis.
Adenoviral infection of VSMC was performed with a
multiplicity of infections (MOI) of 100. After forty-eight hours of
adenoviral infection, total cellular proteins were isolated for
Western blot or migration assays.
Real-time PCR
Quantitative Real-time PCR (q-PCR) was performed using the
SYBRGreen PCR-based protocol in a 384-well plate format
(Applied Biosystems) as described previously [16]. All the primers
used for Real Time PCR analysis have been designated using
Primer Express software 1.5 (Applied Biosystems, Foster City,
CA), and synthesized by Invitrogen Life Technologies (Carlsbad,
CA). The primer sequence sizes are listed in Table 1.
RNA was extracted from frozen aortae or cultured VSMC using
Trizol reagent. RNA (2 mg) was reverse transcribed for 30 minutes
at 48uC using random hexonucleotides according to the
manufacturer’s instructions (Applied Biosystems Foster City CA).
Real-time PCR was performed according to the SYBRGreen PCR
protocol (Applied Biosystems Foster City CA). Each sample has
been tested in quadruplicate. The reaction conditions were:
10 min at 95uC (one cycle); 30 sec at 95uC; 30 sec at 60uC; and
30 sec at 72uC (40 cycles). Gene-specific PCR products were
continuously measured by an ABI PRISM 7900 HT Sequence
Detection System (PE Applied Biosystem Norwalk, CT). The PCR
product sizes were verified by agarose gel electrophoresis. Samples
were normalized to the expression of the ‘‘housekeeping’’ gene, the
18S rRNA, which did not change with age. Data are expressed
using the formula: quantity=10
2(Ct-Y intersept)/slope value) where Ct
represents the threshold cycle value.
Immunostaining
Immunohistochemistry and immunofluorescence were per-
formed according to the methods described previously
[8,11,12,16]. The detailed primary antibodies used for immuno-
staining are listed in Table 2.
Western Blot Analysis
Western blotting of supernatants from thoracic aortae homog-
enates or VSMC lysate products was performed according to the
methods described previously [11,12,16]. Primary antibodies for
the Western blotting are listed in Table 2.
Calpain and MMP2 activity assays
The calpain activity in rat aorte or cultured VSMC was
determined via a measurement of the fraction of calpain-specific
spectrin cleaved products (SBDP), as described previously [54].
Briefly, lysates from rat aortae or cultured VSMC were
immunoblotted with an antibody against a-II-spectrin. This
antibody recognizes intact 280-kD a-II-spectrin and calpain-
specific cleaved 150 and 145-kDa fragments. The spectrin fraction
is calculated by dividing the cleaved spectrin densitometry by total
Table 1. Primers sequences and amplified fragments size used for real-time PCR
Upstream primer sequence Downstream primer sequence Fragment size (bp)
Calpain-1 CCGGGACTTCATACGTGAGT AGGTGCCCTCGTAAAATGTG 110
18s rRNA CGCGGTTCTATTTTGTTGGTTT GCGCCGGTCCAAGAATTT 103
doi:10.1371/journal.pone.0002231.t001
Table 2. Primary antibodies used for immunostaining (IS) and Western blotting (WB)
Antibody Species Titer for IS Titer for WB Source
Calpain-1 Rabbit 1:100 1:2500 Sigma, St. Louis, MO
a-II spectrin Mouse 1:3000 BioMol, Plymouth Meeting, PA
a-SMA Mouse 1:80 DAKO, Glostrup. Denmark
Ang II Rabbit 1:50 Peninsula Laboratories, Inc., Dan Carlos, CA
doi:10.1371/journal.pone.0002231.t002
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the intact densitometry plus the cleaved densitometry.
In addition, casein zymography of VSMC was performed
according to the modified protocol described previously [55].
Cultured VSMCs were collected with lysis buffer containing
50 mM HEPES, 159 mM NaCl, 10%Glycerol, 1%Triton X-100,
5 mM EDTA, 15 mM b-mercaptoethanol, 1 mM PMSF, 2 mg/
mL Leupeptin, into a sterile tube. Cells were homogenized by
vortexing for 30 sec and centrifuging for 15 min at 4uCa t
13,500 rpm. The supernatant was used fresh or stored at 280uC
until use. Casein (0.2%, w/v) was copolymerized with 10%
acrylamide (w/v), HI buffer (25 mM HEPES, 20 mM imidazole,
pH 7.4), 20 mM EGTA as a separation gel, 5% acrylamide (w/v),
HI buffer (no casein) as a stacking gel were poured into minigel
casts (Bio-Rad). Ammonium persulfate (0.04%, w/v) and TEMED
(0.028%, v/v) were used to catalyze the polymerization. 20 mgo f
cell lysate were mixed with 26 sample buffer (0.1 M Tris-HCl
buffer, 10 mM EDTA, 20% glycerol, 0.2% bromophenol blue,
and 0.3 M b-mercaptoethanol). The casein gels were pre-run at
125V with a buffer containing 40 mM HEPES, 30 mM imidazole,
0.625 mM EDTA and 15 mM b-mercaptoethanol, pH 7.4 for
30 min at 4uC. Samples were then loaded into the wells and run
for another 3 hrs at 4uC at 125V. The gel was then removed and
incubated in developing buffer containing 25 mM Tris, 25 mM
MOPS, 20 mM imidazole, 18 mM HEPES, 6.7 mM CaCl2, and
15 mM b-mercaptoethanol with slow shaking for 60 min(with 2
changes of buffer). The gel was then further incubated overnight
(16–20 hr) at 37uC in the same developing buffer. Finally, the gel
was stained with Coomassie blue.
MMP2 activity assays were determined via PAGE gelatin
zymography according to the methods described previously
[8,11,12].
VSMC Migration
The following VSMC Migration was performed according to
the methods described previously [56]. Briefly, modified Boyden
chambers were equipped with 8 mm pore-size polycarbonate filters
(Neuroprobe, Gaithursburg, MD) coated with Matrigel (BD
Biosciences, Palo Alto, CA). VSMC were untreated, or pre-
treated with Ang II (100 nmol/L) only or together with Ci 1, an
inhibitor of calpain (10 mmol/L ); VSMC were infected with
adenovirus harboring calpain-1 (CANP1) or calpatatin (CAST)
cDNA; or infected VSMC were treated with or without GM6001
(15 mmol/L) for 24 hours in 0.1% FBS. Two hundred and twenty
mL of migration medium (MM, DMEM with 0.1% BSA) was
added to the lower chamber with or without platelet-derived
growth factor (PDGF-BB, 10 ng/ml) for chemoattract and
random migration assay, respectively. VSMC (10
6/mL) were
placed in the upper chamber in 200 mL of MM, performed in
triplicate. The assay was stopped after 4 hours at 37uC, and cells
that had crossed the basement membrane and migrated to the
lower side of the filter, were fixed and stained using the HEMA3
system (Curtin Matheson Scientific, Inc., Houston, TX). Four
random fields were counted at 4006magnification for each filter.
Statistical Analysis
All results are expressed as the mean6SEM from at least three
independent experiments. Statistical comparisons for multiple
group differences were made via an ANOVA, followed by
Bonferroni post hoc tests. Two-age group differences were
determined via Student’s t- tests. A p value of ,0.05 was taken
as statistical significance.
Supporting Information
Figure S1 Over-expression of calpain-1 or calpastatin by
adenovirus infection. A. Fluorescence photomicrographs show
that Adenovirus (GFP or CAST) infected into VSMC. GFP
expression was visualized after 48 hrs. Western blots of calpastatin
from VSMC infected with CAST virus (right panel). B.
Adenovirus (GFP or CANP1) infected into VSMC. GFP
expression was visualized by fluorescence microscopy after
48 hrs. Western blots of calpain-1 from VSMC infected with
CANP1 virus (right panel).
Found at: doi:10.1371/journal.pone.0002231.s001 (1.24 MB TIF)
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